Current Good Manufacturing Practices for Transfusion Services (Online Course)

(based on 653 customer ratings)

Author: Suzanne H. Butch, MA, MLS(ASCP)CM, SBB, DLM
Reviewer: Barbara Cebulski, MS, MLS(ASCP)CM

Good manufacturing practices lead to final products or services that consistently meet appropriate specifications and compliance with defined regulations. The main goal of good manufacturing practices is to prevent adulterated products from entering the market place.

This course focuses on transfusion services and the practices related to the manufacturing of blood and blood components. These practices are correlated to the Food and Drug Administration's (FDA's) current good manufacturing practices (cGMP) that are discussed in Title 21 of the US Code of Federal Regulations.

Laboratory personnel who review the cGMP sections of the Code of Federal Regulations (CFR) ensure their transfusion services departments provide safe products that are in compliance with the FDA regulations.

See all available courses »

Continuing Education Credits

  • P.A.C.E.® Contact Hours: 2 hour(s)
  • Florida Board of Clinical Laboratory Science CE - General (Blood Banking / Immunohematology): 2 hour(s)

Objectives

  • Explain what constitutes good manufacturing practices for transfusion services.
  • Locate current Good Manufacturing Practices Regulations (cGMP) in the US Code of Federal Regulations.
  • Identify regulations applicable to situations encountered in the transfusion service laboratory.

Customer Ratings

(based on 653 customer ratings)

Course Outline

  • The Law and Regulations
      • Introduction
      • Current Good Manufacturing Practice (cGMP) Defined
      • Donor vs Transfusion Service
      • Redundancy
      • Good Manufacturing Practices apply to:
  • 211 General Good Manufacturing Practices Correlated to CFR Parts Specific to Transfusion Services
      • Quality Control Unit
      • Personnel Requirements
      • Building and Facilities Requirements
      • Building and Facilities, continued
      • Equipment
      • Control of Components & Reagents
      • Control of Components and Reagents, continued
      • Production and Process Controls
      • Packaging and Label Control
      • Holding & Distribution and Traceability
      • Laboratory Controls
      • Records and Reports
      • Complaint and Adverse Reaction Files
      • Returned and Salvaged Drugs
      • The regulations that are listed in the Code of Federal Regulations (CFR) should be considered:
  • 600 General Biological Good Manufacturing Practices
      • Addresses and Definitions
      • Shipment Temperatures
      • Establishment Inspections
      • Annual Reporting
      • A transfusion service that does not manufacture blood components may be inspected by which of the following organizations for compliance with good man...
  • 606 Current Good Manufacturing Practice for Blood and Blood Components
      • Current Good Manufacturing Practices (cGMP) For Blood and Blood Components
      • Standard Operating Procedures
      • Container Label
      • Specific Label Statements
      • Machine Readable Label
      • Emergency Labeling
      • Autologous Labeling
      • What additional information is required on a label or tie tag of an autologous unit?
      • Compatibility Testing
      • Deviation Reporting
      • Which of the following would require that a biological product deviation be reported to the FDA?
  • 607 Registration Exemptions
      • FDA Registration and Exemptions
      • Which of the following activities could a facility perform and still be exempt for registration and submission of a list of components manufactured?
  • 610 General Biological Product Standards
      • Testing for Communicable Diseases: 21CFR Part 610
      • Donor Deferral & Lookback
      • Dating Period of Blood Components
      • Additional Container Labeling Requirements
      • Which of the following activities would require that a label be added to the blood label indicating the name and location of a second manufacturer?
  • 640 Additional Standards for Blood & Blood Components
      • Title 21 Part 640 Overview
      • Reissue of Blood
      • Red Blood Cells
      • Platelets
      • Plasma
      • Cryoprecipitate
      • 640.120 Alternative Procedures
  • 660 Additional Standards for Diagnostic Substances for Laboratory Tests
      • 21CFR 660.20 Blood Grouping Reagents
      • The specifications for antibody screening cells are found in:
      • Conclusion
  • References
      • References

Additional Information

Level of instruction: Intermediate
 
Intended audience: Laboratory personnel who are involved in the production and processing of blood and blood components, including compatibility testing. This course is also useful for Medical Laboratory Science (MLS)  students and all MLS, MLT, and MT personnel who would like to maintain their knowledge and skills in transfusion medicine.
 
Author: Suzanne H. Butch, MA, MLS(ASCP)CM, SBB, DLM is the Administrative Manager for Healthcare, Blood Bank & Transfusion Service at the University of Michigan Hospitals and Health Centers in Ann Arbor, Michigan. She holds a Bachelors in Medical Technology from the University of Michigan, a Masters Degree in Management and Supervision from Central Michigan University, and Certifications as a Specialist in Blood Bank, as a Quality Audit and as a Diplomate in Laboratory Medicine. She has edited books and written numerous book chapters and articles and has been invited to present numerous lectures in the field of computerization in the blood bank, automation and transfusion medicine.
Reviewer: Barbara Cebulski, MS, MLS(ASCP)CM is a Program Director for MediaLab, Inc., located in Lawrenceville, GA. She has over 30 years experience in the medical laboratory profession as a technologist, section supervisor, and laboratory manager. She also was employed for nine years by the College of American Pathologists in the Laboratory Accreditation Program. Barbara holds a Masters in Instructional Technology from Georgia State University.
 
Course content: This course reviews good manufacturing practices that apply to Transfusion Services and correlates these practices with the regulations that are part of Title 21 of the US Code of Federal Regulations. Laboratory staff in the United States who manufacture blood components are expected to comply with and understand these regulations.




shutterstock 277447430